Background: The optimal antithrombotic strategy in patients undergoing transcatheter aortic valve replacement (TAVR) in undetermined. We sought to assess the incidence and outcomes of single (SAPT) vs. dual antiplatelet therapy… Click to show full abstract
Background: The optimal antithrombotic strategy in patients undergoing transcatheter aortic valve replacement (TAVR) in undetermined. We sought to assess the incidence and outcomes of single (SAPT) vs. dual antiplatelet therapy (DAPT) post TAVR, excluding patients deemed to require anticoagulation
               
Click one of the above tabs to view related content.